(Q43865705)

English

The influence of TP53 mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations

scientific article published on 4 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

The influence of TP53 mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

object named as

Seung Ick Cha

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

11

object named as

Eung Bae Lee

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

object named as

Shin Yup Lee

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

9

object named as

Seung Soo Yoo

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

14

object named as

Jae Yong Park

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

13

object named as

Chang Ho Kim

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

10

object named as

Jaehee Lee

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

object named as

Yup Hwangbo

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Hyo-Sung Jeon

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ji Yun Jeong

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ji Young Park

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Eun Jin Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Guang Jin

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kyung Min Shin

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

4 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Molecular Carcinogenesis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

93-101

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

The TP53 gene, tobacco exposure, and lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Molecular genetics of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Molecular footprints of human lung cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

The new lung cancer staging system

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

TP53 mutations in Korean patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Structural aspects of the p53 protein in relation to gene evolution: a second look.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Assessing TP53 status in human tumours to evaluate clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study.

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.22077

21 January 2018

Identifiers

10.1002/MC.22077

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43865705&oldid=2104015732"